Massimo Puoti spends much of his time researching Immunology, Internal medicine, Hepatitis C virus, Hepatitis C and Hepatitis B virus. His Immunology study integrates concerns from other disciplines, such as Liver disease and Acquired immunodeficiency syndrome. His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Sofosbuvir.
The various areas that Massimo Puoti examines in his Hepatitis C virus study include Coinfection, Chronic liver disease, Liver biopsy and Viral load. His Hepatitis C study combines topics in areas such as Pibrentasvir, Glecaprevir, Transmission, Alpha interferon and Paritaprevir. His Hepatitis B virus study contributes to a more complete understanding of Virology.
Massimo Puoti mainly focuses on Internal medicine, Immunology, Hepatitis C, Hepatitis C virus and Gastroenterology. His Internal medicine research includes elements of Ribavirin and Viral load. Viral disease is closely connected to Acquired immunodeficiency syndrome in his research, which is encompassed under the umbrella topic of Immunology.
His Hepatitis C research includes themes of Transmission, Alpha interferon and Intensive care medicine. His Hepatitis C virus research is multidisciplinary, incorporating elements of Chronic liver disease and Hepatology. He has included themes like Glecaprevir, Genotype and Ritonavir in his Gastroenterology study.
Massimo Puoti mainly investigates Internal medicine, Severe acute respiratory syndrome coronavirus 2, Coronavirus disease 2019, Gastroenterology and Hepatitis C. His Internal medicine study incorporates themes from Pibrentasvir, Hepatitis C virus, Genotype and Glecaprevir. His study in Hepatitis C virus is interdisciplinary in nature, drawing from both Chronic liver disease, Hepatocellular carcinoma, Hepatology and Hepatitis B virus.
His research in Severe acute respiratory syndrome coronavirus 2 intersects with topics in Liver transplantation, Virology, Young adult, Immunology and Coronavirus. His Gastroenterology research incorporates themes from Ribavirin, Retrospective cohort study, Kidney disease and Intention-to-treat analysis. His studies in Hepatitis C integrate themes in fields like Cohort study, Intensive care medicine, Sofosbuvir, Liver disease and Nephritis.
Massimo Puoti focuses on Internal medicine, Coronavirus disease 2019, Severe acute respiratory syndrome coronavirus 2, Hepatitis C virus and Gastroenterology. His research integrates issues of Titer, Pibrentasvir and Glecaprevir in his study of Internal medicine. In his study, Occult, Hbv reactivation, Hepatitis B virus, Ritonavir and Kidney transplantation is strongly linked to Intensive care medicine, which falls under the umbrella field of Coronavirus disease 2019.
His biological study spans a wide range of topics, including Young adult, Serology, Organ transplantation and 2019-20 coronavirus outbreak. His study explores the link between Hepatitis C virus and topics such as Intention-to-treat analysis that cross with problems in Voxilaprevir, Anemia and Hepatocellular carcinoma. His Gastroenterology research integrates issues from Ribavirin, Sofosbuvir and Hepatitis C.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
Nezam Afdhal;Stefan Zeuzem;Paul Kwo;Mario Chojkier.
The New England Journal of Medicine (2014)
EASL Recommendations on Treatment of Hepatitis C
Jean-Michel Pawlotsky;Alessio Aghemo;Geoffrey Dusheiko;Xavier Forns.
Journal of Hepatology (2018)
Statements from the Taormina expert meeting on occult hepatitis B virus infection.
Giovanni Raimondo;Jean Pierre Allain;Maurizia R. Brunetto;Marie Annick Buendia.
Journal of Hepatology (2008)
A meta‐analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma
Francesco Donato;Paolo Boffetta;Massimo Puoti.
International Journal of Cancer (1998)
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel.
Markus Cornberg;Homie A. Razavi;Alfredo Alberti;Enos Bernasconi.
Liver International (2011)
Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel.
Vincent Soriano;Massimo Puoti;Mark Sulkowski;Antonietta Cargnel.
Selective depletion in HIV infection of T cells that bear specific T cell receptor V beta sequences.
Luisa Imberti;Alessandra Sottini;Alessandra Bettinardi;Massimo Puoti.
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
JK Rockstroh;S Bhagani;Y Benhamou;R Bruno.
Hiv Medicine (2008)
Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.
Andrea De Luca;Roberto Bugarini;Alessandro Cozzi Lepri;Massimo Puoti.
JAMA Internal Medicine (2002)
Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome.
Massimo Puoti;Raffaele Bruno;Vincent Soriano;Francesco Donato.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: